Effect of dual glucose-dependent insulinotropic peptide/glucagon-like peptide-1 receptor agonist on weight loss in subjects with obesity

Overview of attention for article published in Frontiers in endocrinology, February 2023

Altmetric Badge

About this Attention Score

In the top 5% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (95th percentile)
High Attention Score compared to outputs of the same age and source (98th percentile)

So far, Altmetric has seen 13 X posts from 12 X users, with an upper bound of 51,885 followers.

RT @DanielJDrucker: Based on the promising results of SURMOUNT-1 the authors review the data for #Tirzepatide #Obesity @FrontiersIn https:/…

RT @DanielJDrucker: Based on the promising results of SURMOUNT-1 the authors review the data for #Tirzepatide #Obesity @FrontiersIn https:/…

RT @DanielJDrucker: Based on the promising results of SURMOUNT-1 the authors review the data for #Tirzepatide #Obesity @FrontiersIn https:/…

RT @DanielJDrucker: Based on the promising results of SURMOUNT-1 the authors review the data for #Tirzepatide #Obesity @FrontiersIn https:/…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 9 additional X posts.